The apparently very variable potency of the anti-depressant fluoxetine.

The anti-depressant fluoxetine is widely present in the aquatic environment. Typical river concentrations are in the low ng/L range. Many ecotoxicity studies have assessed the effects of this pharmaceutical on a range of aquatic species. Some studies report that ng, or even pg, per litre concentrations cause effects, whereas other studies report that effects only occur when the water concentration is in the μg/L range. It seems unlikely that all reported effects will be repeatable. Many of the studies have considerable limitations. Currently it is impossible to ascertain what environmental concentrations of fluoxetine pose a risk to aquatic organisms. The key question can be answered only by high quality, reproducible research.

[1]  John P. Sumpter,et al.  The Read-Across Hypothesis and Environmental Risk Assessment of Pharmaceuticals , 2013, Environmental science & technology.

[2]  E. Furlong,et al.  Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows. , 2011, Aquatic toxicology.

[3]  P. Fong,et al.  Norfluoxetine Induces Spawning and Parturition in Estuarine and Freshwater Bivalves , 2008, Bulletin of environmental contamination and toxicology.

[4]  Alex T Ford,et al.  Anti-depressants make amphipods see the light. , 2010, Aquatic toxicology.

[5]  H. Köhler,et al.  Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). , 2004, Aquatic toxicology.

[6]  R. Skalko,et al.  Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). , 2007, Neurotoxicology and teratology.

[7]  D. Dietrich,et al.  Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). , 2005, Aquatic toxicology.

[8]  Hélène Budzinski,et al.  Pharmaceuticals in Rivers of Two Regions with Contrasted Socio-Economic Conditions: Occurrence, Accumulation, and Comparison for Ukraine and France , 2012, Water, Air, & Soil Pollution.

[9]  V. Trudeau,et al.  Waterborne fluoxetine disrupts feeding and energy metabolism in the goldfish Carassius auratus. , 2010, Aquatic toxicology.

[10]  Paola Valbonesi,et al.  The mode of action (MOA) approach reveals interactive effects of environmental pharmaceuticals on Mytilus galloprovincialis. , 2013, Aquatic toxicology.

[11]  Allan V. Kalueff,et al.  Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish , 2009, Behavioural Brain Research.

[12]  J. Sekizawa,et al.  The effects of pH on fluoxetine in Japanese medaka (Oryzias latipes): acute toxicity in fish larvae and bioaccumulation in juvenile fish. , 2008, Chemosphere.

[13]  M. Slattery,et al.  Waterborne and sediment toxicity of fluoxetine to select organisms. , 2003, Chemosphere.

[14]  H. Yoshioka,et al.  Characterization and expression of serotonin transporter genes in zebrafish. , 2006, The Tohoku journal of experimental medicine.

[15]  Jess G. Kohlert,et al.  Decreased Aggressive and Locomotor Behaviors in Betta Splendens after Exposure to Fluoxetine , 2012, Psychological reports.

[16]  J. Pittman,et al.  iPhone® applications as versatile video tracking tools to analyze behavior in zebrafish (Danio rerio) , 2013, Pharmacology Biochemistry and Behavior.

[17]  T. L. Dzieweczynski,et al.  Fluoxetine alters behavioral consistency of aggression and courtship in male Siamese fighting fish, Betta splendens , 2012, Physiology & Behavior.

[18]  M. J. Barry Effects of fluoxetine on the swimming and behavioural responses of the Arabian killifish , 2013, Ecotoxicology.

[19]  D. Dietrich,et al.  Physiological Endpoints for Potential SSRI Interactions in Fish , 2008, Critical reviews in toxicology.

[20]  Y. Valcárcel,et al.  Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan area (Spain). , 2010, Environment international.

[21]  C. Barata,et al.  Low environmental levels of fluoxetine induce spawning and changes in endogenous estradiol levels in the zebra mussel Dreissena polymorpha. , 2012, Aquatic toxicology.

[22]  V. Langlois,et al.  Waterborne fluoxetine disrupts the reproductive axis in sexually mature male goldfish, Carassius auratus. , 2010, Aquatic toxicology.

[23]  Rik Oldenkamp,et al.  Do concentrations of ethinylestradiol, estradiol, and diclofenac in European rivers exceed proposed EU environmental quality standards? , 2013, Environmental science & technology.

[24]  Laura N. Vandenberg,et al.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. , 2012, Endocrine reviews.

[25]  J. Godwin,et al.  Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment , 2013, BMC Genomics.

[26]  Michel Boulouard,et al.  Effects of perinatal exposure to waterborne fluoxetine on memory processing in the cuttlefish Sepia officinalis. , 2013, Aquatic toxicology.

[27]  Alvine C Mehinto,et al.  Uptake and biological effects of environmentally relevant concentrations of the nonsteroidal anti-inflammatory pharmaceutical diclofenac in rainbow trout (Oncorhynchus mykiss). , 2010, Environmental science & technology.

[28]  J. Cook,et al.  A Theoretical Model for Utilizing Mammalian Pharmacology and Safety Data to Prioritize Potential Impacts of Human Pharmaceuticals to Fish , 2003 .

[29]  Bryan W Brooks,et al.  Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. , 2010, Toxicology letters.

[30]  R. Blakely,et al.  Pharmacological profile of antidepressants and related compounds at human monoamine transporters. , 1997, European journal of pharmacology.

[31]  Stewart F Owen,et al.  The value of repeating studies and multiple controls: replicated 28‐day growth studies of rainbow trout exposed to clofibric acid , 2010, Environmental toxicology and chemistry.

[32]  Elise Cartmell,et al.  The significance of hazardous chemicals in wastewater treatment works effluents. , 2012, The Science of the total environment.

[33]  Matthew J Winter,et al.  Using data from drug discovery and development to aid the aquatic environmental risk assessment of human pharmaceuticals: Concepts, considerations, and challenges , 2010, Integrated environmental assessment and management.

[34]  J. Sumpter,et al.  Are some invertebrates exquisitely sensitive to the human pharmaceutical fluoxetine? , 2014, Aquatic toxicology.

[35]  J. Schwaiger,et al.  Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. , 2004, Aquatic toxicology.

[36]  T. Newton,et al.  Environmental occurrence and reproductive effects of the pharmaceutical fluoxetine in native freshwater mussels , 2010, Environmental toxicology and chemistry.

[37]  J. Sumpter,et al.  DICLOFENAC: NEW DATA ON CHRONIC TOXICITY AND BIOCONCENTRATION IN FISH , 2013, Environmental toxicology and chemistry.

[38]  P. Fong,et al.  Antidepressants cause foot detachment from substrate in five species of marine snail. , 2013, Marine environmental research.

[39]  V. Winder,et al.  Fluoxetine effects on sheepshead minnow (Cyprinodon variegatus) locomotor activity , 2012, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.